Skip to main content

Early Psychosis

1
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Partner Therapeutics
Partner TherapeuticsMA - Lexington
1 program
1
Feel-Good- GroupPhase 11 trial
Active Trials
NCT04592042Completed36Est. Jan 2022
Integrated Biosciences
Integrated BiosciencesCA - San Carlos
2 programs
AIM_ATN/A1 trial
Peer-led self-management programN/A1 trial
Active Trials
NCT06192602Active Not Recruiting126Est. Jan 2027
NCT04166019Completed180Est. Jul 2025
Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
1 program
Decision aidN/A1 trial
Active Trials
NCT04373590Completed18Est. Aug 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Partner TherapeuticsFeel-Good- Group
Integrated BiosciencesAIM_AT
Integrated BiosciencesPeer-led self-management program
Temple TherapeuticsDecision aid

Clinical Trials (4)

Total enrollment: 360 patients across 4 trials

Intervention to Improve Coping With Negative Emotions in Patients With Psychosis (Feel-Good-Study)

Start: Jan 2021Est. completion: Jan 202236 patients
Phase 1Completed

Effects of an Acceptance-based Medication Adherence Therapy for Recent-onset Psychosis

Start: Feb 2023Est. completion: Jan 2027126 patients
N/AActive Not Recruiting
NCT04166019Integrated BiosciencesPeer-led self-management program

Effect of a Peer-led Self-management Program for Recent-onset Psychosis

Start: Dec 2020Est. completion: Jul 2025180 patients
N/ACompleted

Decision-making and Decision Support Among Emerging Adults With First Episode Psychosis

Start: Feb 2019Est. completion: Aug 202018 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.